175 related articles for article (PubMed ID: 32581555)
1. Salinomycin and Sulforaphane Exerted Synergistic Antiproliferative and Proapoptotic Effects on Colorectal Cancer Cells by Inhibiting the PI3K/Akt Signaling Pathway in vitro and in vivo.
Liu F; Lv RB; Liu Y; Hao Q; Liu SJ; Zheng YY; Li C; Zhu C; Wang M
Onco Targets Ther; 2020; 13():4957-4969. PubMed ID: 32581555
[TBL] [Abstract][Full Text] [Related]
2. Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133
Klose J; Eissele J; Volz C; Schmitt S; Ritter A; Ying S; Schmidt T; Heger U; Schneider M; Ulrich A
BMC Cancer; 2016 Nov; 16(1):896. PubMed ID: 27855654
[TBL] [Abstract][Full Text] [Related]
3. Novel combination of salinomycin and resveratrol synergistically enhances the anti-proliferative and pro-apoptotic effects on human breast cancer cells.
Dewangan J; Tandon D; Srivastava S; Verma AK; Yapuri A; Rath SK
Apoptosis; 2017 Oct; 22(10):1246-1259. PubMed ID: 28748373
[TBL] [Abstract][Full Text] [Related]
4. Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis.
Mokhtari RB; Qorri B; Baluch N; Sparaneo A; Fabrizio FP; Muscarella LA; Tyker A; Kumar S; Cheng HM; Szewczuk MR; Das B; Yeger H
Oncotarget; 2021 Jul; 12(15):1470-1489. PubMed ID: 34316328
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane suppresses carcinogenesis of colorectal cancer through the ERK/Nrf2‑UDP glucuronosyltransferase 1A metabolic axis activation.
Hao Q; Wang M; Sun NX; Zhu C; Lin YM; Li C; Liu F; Zhu WW
Oncol Rep; 2020 Apr; 43(4):1067-1080. PubMed ID: 32323779
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane induces apoptosis in adipocytes via Akt/p70s6k1/Bad inhibition and ERK activation.
Yao A; Shen Y; Wang A; Chen S; Zhang H; Chen F; Chen Z; Wei H; Zou Z; Shan Y; Zhang X
Biochem Biophys Res Commun; 2015 Oct; 465(4):696-701. PubMed ID: 26296464
[TBL] [Abstract][Full Text] [Related]
7. Salinomycin induces apoptosis and differentiation in human acute promyelocytic leukemia cells.
Zhao Y; Zhong L; Liu L; Yao SF; Chen M; Li LW; Shan ZL; Xiao CL; Gan LG; Xu T; Liu BZ
Oncol Rep; 2018 Aug; 40(2):877-886. PubMed ID: 29989650
[TBL] [Abstract][Full Text] [Related]
8. Combination of Formononetin and Sulforaphane Natural Drug Repress the Proliferation of Cervical Cancer Cells via Impeding PI3K/AKT/mTOR Pathway.
Jiang P; Jiang W; Li X; Zhu Q
Appl Biochem Biotechnol; 2024 Feb; ():. PubMed ID: 38401043
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation.
Chen H; Landen CN; Li Y; Alvarez RD; Tollefsbol TO
Exp Cell Res; 2013 Mar; 319(5):697-706. PubMed ID: 23333498
[TBL] [Abstract][Full Text] [Related]
10. Effects of Salidroside Combined with Paclitaxel on Proliferation, Migration, and Epithelial Mesenchyme of Colorectal Cancer Cells.
Hao Y; Li Z; Chang M; Zhang X
Drug Des Devel Ther; 2022; 16():4079-4089. PubMed ID: 36465266
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN).
Islam SS; Mokhtari RB; Akbari P; Hatina J; Yeger H; Farhat WA
Target Oncol; 2016 Apr; 11(2):209-27. PubMed ID: 26453055
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of cancer cells through reduction of total Akt and downregulation of salinomycin-induced pAkt, pGSk3β, pTSC2, and p4EBP1 by cotreatment with MK-2206.
Choi AR; Kim JH; Yoon S
Biomed Res Int; 2014; 2014():295760. PubMed ID: 25114899
[TBL] [Abstract][Full Text] [Related]
13. mTOR inhibitor PP242 increases antitumor activity of sulforaphane by blocking Akt/mTOR pathway in esophageal squamous cell carcinoma.
Lu Z; Zhang Y; Xu Y; Wei H; Zhao W; Wang P; Li Y; Hou G
Mol Biol Rep; 2022 Jan; 49(1):451-461. PubMed ID: 34731371
[TBL] [Abstract][Full Text] [Related]
14. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
[TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition of the growth of MDA-MB-231 cells in triple-negative breast cancer by salinomycin combined with 17-AAG and its mechanism.
He D; Wu B; Du J; Li L; Zhao J
Oncol Lett; 2022 Apr; 23(4):138. PubMed ID: 35317027
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane Exhibits Cytotoxic Effects against Primary Effusion Lymphoma Cells by Suppressing p38MAPK and AKT Phosphorylation.
Ishiura Y; Ishimaru H; Watanabe T; Fujimuro M
Biol Pharm Bull; 2019; 42(12):2109-2112. PubMed ID: 31787726
[TBL] [Abstract][Full Text] [Related]
17. Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells.
Bryant CS; Kumar S; Chamala S; Shah J; Pal J; Haider M; Seward S; Qazi AM; Morris R; Semaan A; Shammas MA; Steffes C; Potti RB; Prasad M; Weaver DW; Batchu RB
Mol Cancer; 2010 Mar; 9():47. PubMed ID: 20196847
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of growth inhibitory response of Resveratrol and Salinomycin combinations against triple negative breast cancer cells.
Rai G; Suman S; Mishra S; Shukla Y
Biomed Pharmacother; 2017 May; 89():1142-1151. PubMed ID: 28298074
[TBL] [Abstract][Full Text] [Related]
19. Auranofin Enhances Sulforaphane-Mediated Apoptosis in Hepatocellular Carcinoma Hep3B Cells through Inactivation of the PI3K/Akt Signaling Pathway.
Hwangbo H; Kim SY; Lee H; Park SH; Hong SH; Park C; Kim GY; Leem SH; Hyun JW; Cheong J; Choi YH
Biomol Ther (Seoul); 2020 Sep; 28(5):443-455. PubMed ID: 32856616
[TBL] [Abstract][Full Text] [Related]
20. Enhanced anti-colorectal cancer effects of carfilzomib combined with CPT-11 via downregulation of nuclear factor-κB in vitro and in vivo.
Tang W; Su G; Li J; Liao J; Chen S; Huang C; Liu F; Chen Q; Ye Y
Int J Oncol; 2014 Sep; 45(3):995-1010. PubMed ID: 24968890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
